ENvue Medical announces launch of new development, integration program

ENvue Medical (FEED) announced the launch of a new development and integration program leveraging vibration-based technology from its NanoVibronix division to address pain and discomfort associated with indwelling nasogastric tubes. Doron Besser, MD, CEO of ENvue Medical, commented, “We believe that this program represents a disciplined platform expansion initiative focused on improving the overall enteral care experience by addressing patient comfort during prolonged NG tube use. While this initiative is exploratory in nature and does not represent a commercial product launch or regulatory clearance announcement, we believe the data will be invaluable for our ongoing commercial efforts of our technology.”

Claim 70% Off TipRanks Premium

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on FEED:

Disclaimer & DisclosureReport an Issue

ENvue Medical’s UroShield Kit secures reimbursement in the UK ENvue Medical names David Johnson as chairman of the board

Ver comentarios